1. Zipes DP, Braunwald E: A Textbook of Cardiovascular Medicine. Philadelphia, Saunders, 2004.
2. Bonow RO, Carabello B, de Leon
AC Jr, et al: Guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease).
Circulation 1998; 98:1949.
[PubMed: 9799219]
3. Spencer FC: A plea for early, open mitral commissurotomy.
Am Heart J 1978; 95:668.
[PubMed: 637004]
4. Vincens JJ, Temizer D, Post JR, et al: Long-term outcome of cardiac surgery in patients with mitral stenosis and severe pulmonary hypertension. Circulation 1995; 92:II137.
5. Li M, Dumesnil JG, Mathieu P, Pibarot P: Impact of valve prosthesis-patient mismatch on pulmonary arterial pressure after mitral valve replacement.
J Am Coll Cardiol 2005; 45:1034.
[PubMed: 15808760]
6. Palacios IF, Tuzcu ME, Weyman AE, et al: Clinical follow-up of patients undergoing percutaneous mitral balloon valvotomy.
Circulation 1995; 91:671.
[PubMed: 7828292]
7. Reyes VP, Raju BS, Wynne J, et al: Percutaneous balloon valvuloplasty compared with open surgical commissurotomy for mitral stenosis.
NEJM 1994; 331:961.
[PubMed: 8084354]
8. National Heart, Lung, and Blood Institute Balloon Valvuloplasty Registry: Complications and mortality of percutaneous balloon commissurotomy. Circulation 1992; 85:2014.
9. Cohn LH, Allred EN, Cohn LA, et al: Long-term results of open mitral valve reconstruction for mitral stenosis.
Am J Cardiol 1985; 55:731.
[PubMed: 3976518]
10. Glower DD, Landolfo KP, Davis RD, et al: Comparison of open mitral commissurotomy with mitral valve replacement with or without chordal preservation in patients with mitral stenosis. Circulation 1998; 98:II-120.
11. el Asmar B, Acker M, Couetil JP, et al: Mitral valve repair in the extensively calcified mitral valve annulus. Ann Thorac Surg 1991; 52:66.
12. Enriquez-Sarano M, Tajik AJ, Schaff HV, et al: Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation.
Circulation 1994; 90:830.
[PubMed: 8044955]
13. Hellgren L, Kvidal P, Horte LG, et al: Survival after mitral valve replacement: rationale for surgery before occurrence of severe symptoms.
Ann Thorac Surg 2004; 78:1241.
[PubMed: 15464479]
14. Ling LH, Enriquez-Sarano M, Seward JB, et al: Clinical outcome of mitral regurgitation due to flail leaflet.
NEJM 1996; 335:1417.
[PubMed: 8875918]
15. Stewart WJ: Choosing the “golden moment” for mitral valve repair.
J Am Coll Cardiol 1994; 24:1544.
[PubMed: 7930288]
16. Tavel ME, Carabello BA: Chronic mitral regurgitation: when and how to operate.
Chest 1998; 113:1399.
[PubMed: 9596325]
17. Tribouilloy CM, Enriquez-Sarano M, Schaff HV, et al: Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: rationale for optimizing surgical indications.
Circulation 1999; 99:400.
[PubMed: 9918527]
18. Kizilbash AM, Hundley WG, Willett DL, et al: Comparison of quantitative Doppler with magnetic resonance imaging for assessment of the severity of mitral regurgitation.
Am J Cardiol 1998; 81:792.
[PubMed: 9527098]
19. Malm S, Frigstad S, Sagberg E, et al: Accurate and reproducible measurement of left ventricular volume and ejection fraction by contrast echocardiography: a comparison with magnetic resonance imaging.
J Am Coll Cardiol 2004; 44:1030.
[PubMed: 15337215]
20. Enriquez-Sarano M, Tajik AJ, Schaff HV, et al: Echocardiographic prediction of left ventricular function after correction of mitral regurgitation: results and clinical implications.
J Am Coll Cardiol 1994; 24:1536.
[PubMed: 7930287]
21. Timmis SB, Kirsh MM, Montgomery DG, Starling MR: Evaluation of left ventricular ejection fraction as a measure of pump performance in patients with chronic mitral regurgitation.
Cathet Cardiovasc Intervent 2000; 49:290.
[PubMed: 10700061]
22. Kontos GJ Jr, Schaff HV, Gersh BJ, Bove AA: Left ventricular function in subacute and chronic mitral regurgitation: effect on function early postoperatively.
J Thorac Cardiovasc Surg 1989; 98:163.
[PubMed: 2755149]
23. Nakano S, Sakai K, Taniguchi K, et al: Relation of impaired left ventricular function in mitral regurgitation to left ventricular contractile state after mitral valve replacement.
Am J Cardiol 1994; 73:70.
[PubMed: 8279381]
24. Matsumura T, Ohtaki E, Tanaka K, et al: Echocardiographic prediction of left ventricular dysfunction after mitral valve repair for mitral regurgitation as an indicator to decide the optimal timing of repair.
J Am Coll Cardiol 2003; 42:458.
[PubMed: 12906972]
25. Wisenbaugh TSD, Sareli P: Prediction of outcome after valve replacement for rheumatic mitral regurgitation in the era of chordal preservation.
Circulation 1994; 89:191.
[PubMed: 8281646]
26. Braunberger E, Deloche A, Berrebi A, et al: Very long-term results (more than 20 years) of valve repair with Carpentier's techniques in nonrheumatic mitral valve insufficiency. Circulation 2001; 104:I-8.
27. Cohn LH, Allred EN, Cohn LA, et al: Early and late risk of mitral valve replacement. A 12-year concomitant comparison of the porcine bioprosthetic and prosthetic disc mitral valves.
J Thorac Cardiovasc Surg 1985; 90:872.
[PubMed: 4068737]
28. Cohn LH, Couper GS, Aranki SF, et al: The long-term results of mitral valve reconstruction for the “floppy” valve.
J Card Surg 1994; 9:278.
[PubMed: 8186581]
29. Cosgrove DM, Chavez AM, Lytle BW, et al: Results of mitral valve reconstruction. Circulation 1986; 74:I-82.
30. Greelish JP, Cohn LH, Leacche M, et al: Minimally invasive mitral valve repair suggests earlier operations for mitral valve disease.
J Thorac Cardiovasc Surg 2003; 126:365; discussion 371.
[PubMed: 12928632]
31. Asmar BE, Perrier P, Couetil J, Carpentier A: Failures in reconstructive mitral valve surgery.
J Med Liban 1991; 39:7.
[PubMed: 1941982]
32. Chauvaud S, Fuzellier JF, Berrebi A, et al: Long-term (29 years) results of reconstructive surgery in rheumatic mitral valve insufficiency. Circulation 2001; 104:I-12.
33. Byrne JG, Aranki SF, Cohn LH: Repair versus replacement of mitral valve for treating severe ischemic mitral regurgitation.
Coron Artery Dis 2000; 11:31.
[PubMed: 10715803]
34. Cohn LH, Rizzo RJ, Adams DH, et al: The effect of pathophysiology on the surgical treatment of ischemic mitral regurgitation: operative and late risks of repair versus replacement.
Eur J Cardiothorac Surg 1995; 9:568.
[PubMed: 8562102]
35. Grossi EA, Goldberg JD, LaPietra A, et al: Ischemic mitral valve reconstruction and replacement: comparison of long-term survival and complications.
J Thorac Cardiovasc Surg 2001; 122:1107.
[PubMed: 11726886]
36. Alexiou C, Langley SM, Stafford H, et al: Surgical treatment of infective mitral valve endocarditis: predictors of early and late outcome.
J Heart Valve Dis 2000; 9:327.
[PubMed: 10888086]
37. Aranki SF, Adams DH, Rizzo RJ, et al: Determinants of early mortality and late survival in mitral valve endocarditis. Circulation 1995; 92:II-143.
38. Mihaljevic T, Paul S, Leacche M, et al: Tailored surgical therapy for acute native mitral valve endocarditis.
J Heart Valve Dis 2004; 13:210.
[PubMed: 15086259]
39. Williams MA, van Riet S: The On-X heart valve: mid-term results in a poorly anticoagulated population.
J Heart Valve Dis 2006; 15(1):80-86.
[PubMed: 16480016]
40. Jamieson WR, von Lipinski O, Miyagishima RT, et al: Performance of bioprostheses and mechanical prostheses assessed by composites of valve-related complications to 15 years after mitral valve replacement.
J Thorac Cardiovasc Surg 2005; 129:1301.
[PubMed: 15942570]
41. Grunkemeier GL, Jamieson WR, Miller DC, Starr A: Actuarial versus actual risk of porcine structural valve deterioration.
J Thorac Cardiovasc Surg 1994; 108:709.
[PubMed: 7934107]
42. Peterseim DS, Cen YY, Cheruvu S, et al: Long-term outcome after biologic versus mechanical aortic valve replacement in 841 patients.
J Thorac Cardiovasc Surg 1999; 117:890.
[PubMed: 10220680]
43. Angell WW, Pupello DF, Bessone LN, et al: Influence of coronary artery disease on structural deterioration of porcine bioprostheses. Ann Thorac Surg 1995; 60:S276.
44. DiSesa VJ, Cohn LH, Collins JJ Jr, et al: Determinants of operative survival following combined mitral valve replacement and coronary revascularization.
Ann Thorac Surg 1982; 34:482.
[PubMed: 6982691]
45. Edwards FH, Peterson ED, Coombs LP, et al: Prediction of operative mortality after valve replacement surgery.
J Am Coll Cardiol 2001; 37:885.
[PubMed: 11693766]
46. Jones EL, Weintraub WS, Craver JM, et al: Interaction of age and coronary disease after valve replacement: implications for valve selection.
Ann Thorac Surg 1994; 58:378; discussion 384.
[PubMed: 8067835]
47. Schoen FJ, Collins JJ Jr, Cohn LH: Long-term failure rate and morphologic correlations in porcine bioprosthetic heart valves.
Am J Cardiol 1983; 51:957.
[PubMed: 6829472]
48. Thourani VH, Weintraub WS, Craver JM, et al: Influence of concomitant CABG and urgent/emergent status on mitral valve replacement surgery.
Ann Thorac Surg 2000; 70:778; discussion 783.
[PubMed: 11016309]
49. Burdon TA, Miller DC, Oyer PE, et al: Durability of porcine valves at fifteen years in a representative North American patient population.
J Thorac Cardiovasc Surg 1992; 103:238; discussion 251.
[PubMed: 1735989]
50. Cohn LH, Collins JJ Jr, Rizzo RJ, et al: Twenty-year follow-up of the Hancock modified orifice porcine aortic valve. Ann Thorac Surg 1998; 66:S30.
51. Corbineau H, Du Haut Cilly FB, Langanay T, et al: Structural durability in Carpentier Edwards standard bioprosthesis in the mitral position: a 20-year experience.
J Heart Valve Dis 2001; 10:443.
[PubMed: 11499587]
52. Jamieson WR, Burr LH, Munro AI, Miyagishima RT: Carpentier-Edwards standard porcine bioprosthesis: a 21-year experience. Ann Thorac Surg 1998; 66:S40.
53. Khan SS, Chaux A, Blanche C, et al: A 20-year experience with the Hancock porcine xenograft in the elderly. Ann Thorac Surg 1998; 66:S35.
54. van Doorn CA, Stoodley KD, Saunders NR, et al: Mitral valve replacement with the Carpentier-Edwards standard bioprosthesis: performance into the second decade. Eur J Cardiothorac Surg 1995; 9:253.
55. Pupello DF, Bessone LN, Hiro SP, et al: Bioprosthetic valve longevity in the elderly: an 18-year longitudinal study. Ann Thorac Surg 1995; 60:S270; discussion S275.
56. Jamieson WR, Tyers GF, Janusz MT, et al: Age as a determinant for selection of porcine bioprostheses for cardiac valve replacement: experience with Carpentier-Edwards standard bioprosthesis.
Can J Cardiol 1991; 7:181.
[PubMed: 2070287]
57. Badduke BR, Jamieson WR, Miyagishima RT, et al: Pregnancy and childbearing in a population with biologic valvular prostheses.
J Thorac Cardiovasc Surg 1991; 102:179.
[PubMed: 1865693]
58. Jamieson WR, Miller DC, Akins CW, et al: Pregnancy and bioprostheses: influence on structural valve deterioration. Ann Thorac Surg 1995; 60:S282; discussion S287.
59. Mihaljevic T, Paul S, Leacche M, et al: Valve replacement in women of childbearing age: influences on mother, fetus and neonate.
J Heart Valve Dis 2005; 14:151.
[PubMed: 15792173]
60. Sareli P, England MJ, Berk MR, et al: Maternal and fetal sequelae of anticoagulation during pregnancy in patients with mechanical heart valve prostheses.
Am J Cardiol 1989; 63:1462.
[PubMed: 2729133]
61. Ali M, Iung B, Lansac E, et al: Homograft replacement of the mitral valve: eight-year results.
J Thorac Cardiovasc Surg 2004; 128:529.
[PubMed: 15457153]
62. Deac RF, Simionescu D, Deac D: New evolution in mitral physiology and surgery: mitral stentless pericardial valve. Ann Thorac Surg 1995; 60:S433.
63. Gulbins H, Kreuzer E, Uhlig A, Reichart B: Mitral valve surgery utilizing homografts: early results.
J Heart Valve Dis 2000; 9:222.
[PubMed: 10772040]
64. Kumar AS, Choudhary SK, Mathur A, et al: Homograft mitral valve replacement: five years' results.
J Thorac Cardiovasc Surg 2000; 120:450.
[PubMed: 10962404]
65. Chauvaud S, Waldmann T, d'Attellis N, et al: Homograft replacement of the mitral valve in young recipients: midterm results.
Eur J Cardiothorac Surg 2003; 23:560.
[PubMed: 12694776]
66. Hofmann B, Cichon R, Knaut M, et al: Early experience with a quadrileaflet stentless mitral valve. Ann Thorac Surg 2001; 71:S323.
67. Lehmann S, Walther T, Kempfert J, et al: Stentless mitral valve implantation in comparison to conventional mitral valve repair or replacement at five years.
Thorac Cardiovasc Surg 2006; 54:10.
[PubMed: 16485182]
68. Vrandecic MO, Fantini FA, Gontijo BF, et al: Surgical technique of implanting the stentless porcine mitral valve. Ann Thorac Surg 1995; 60:S439.
69. Athanasiou T, Cherian A, Ross D: The Ross II procedure: pulmonary autograft in the mitral position.
Ann Thorac Surg 2004; 78:1489.
[PubMed: 15464534]
70. Brown JW, Ruzmetov M, Turrentine MW, Rodefeld MD: Mitral valve replacement with the pulmonary autograft: Ross II procedure with Kabanni modification.
Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2004; 7:107.
[PubMed: 15283360]
71. Kabbani SS, Jamil H, Hammoud A, et al: The mitral pulmonary autograft: assessment at midterm.
Ann Thorac Surg 2004; 78:60; discussion 65.
[PubMed: 15223403]
72. Cohn LH: Cardiac Surgery in the Adult. New York, McGraw Hill, 2008.
73. Cordoba M, Almeida P, Martinez P, et al: Invasive Assessment of Mitral Valve Prostheses. New York, Futura, 1987; p 369.
74. Khuri SF, Folland ED, Sethi GK, et al: Six month postoperative hemodynamics of the Hancock heterograft and the Bjork-Shiley prosthesis: results of a Veterans Administration cooperative prospective, randomized trial.
J Am Coll Cardiol 1988; 12:8.
[PubMed: 3288680]
75. Pelletier C, Chaitman B, Bonan R, Dyrda I: Hemodynamic Evaluation of the Carpentier-Edwards Standard and Improved Annulus Bioprostheses. New York, Yorke Medical Books, 1982; p 96.
76. Horskotte D, Loogen F, Birckson B: Is the Late Outcome of Heart Valve Replacement Influenced by the Hemodynamics of the Heart Valve Substitute? New York, Springer-Verlag, 1986; p 55.
77. Butterfield M, Fisher J, Davies GA, Spyt TJ: Comparative study of the hydrodynamic function of the CarboMedics valve.
Ann Thorac Surg 1991; 52:815.
[PubMed: 1929635]
78. Agathos EA, Starr A: Mitral valve replacement.
Curr Probl Surg 1993; 30:481.
[PubMed: 8325048]
79. Miller DC, Oyer PE, Stinson EB, et al: Ten to fifteen year reassessment of the performance characteristics of the Starr-Edwards Model 6120 mitral valve prosthesis.
J Thorac Cardiovasc Surg 1983; 85:1.
[PubMed: 6848878]
80. Murday AJ, Hochstitzky A, Mansfield J, et al: A prospective, controlled trial of St Jude versus Starr-Edwards aortic and mitral valve prostheses.
Ann Thorac Surg 2003; 76:66; discussion 73.
[PubMed: 12842515]
81. Hall KV: The Medtronic-Hall valve: a design in 1977 to improve the results of valve replacement. Eur J Cardiothorac Surg 1992; 6:S64.
82. Butchart E: Early clinical and hemodynamic results with Hall-Kaster valve, in Medtronic International Valve Symposium. Lisbon, Portugal, Congress Books, 1981; p 159.
83. Grunkemeier GL, Starr A, Rahimtoola SH: Prosthetic heart valve performance: long-term follow-up.
Curr Probl Cardiol 1992; 17:329.
[PubMed: 1499328]
84. Akalin H, Corapcioglu ET, Ozyurda U, et al: Clinical evaluation of the Omniscience cardiac valve prosthesis: follow-up of up to 6 years.
J Thorac Cardiovasc Surg 1992; 103:259.
[PubMed: 1735991]
85. DeWall R, Pelletier LC, Panebianco A, et al: Five-year clinical experience with the Omniscience cardiac valve.
Ann Thorac Surg 1984; 38:275.
[PubMed: 6476951]
86. Watanabe N, Abe T, Yamada O, et al: Comparative analysis of Omniscience and Omnicarbon prosthesis after aortic valve replacement. Jpn J Artif Organs 1989; 18:773.
87. Emery RW, Nicoloff DM: St Jude Medical cardiac valve prosthesis: in vitro studies.
J Thorac Cardiovasc Surg 1979; 78:269.
[PubMed: 459535]
88. Nair CK, Mohiuddin SM, Hilleman DE, et al: Ten-year results with the St Jude Medical prosthesis.
Am J Cardiol 1990; 65:217.
[PubMed: 2296890]
89. Champsaur G, Gressier M, Niret J, et al: When Are Hemodynamics Important for the Selection of a Prosthetic Heart Valve? New York, Springer-Verlag, 1986; p 71.
90. D'Alessandro L, Narducci C, Pucci A, et al: The Use of Mechanical Valves in the Treatment of Valvular Heart Disease. New York, Springer-Verlag, 1986; p 31.
91. Laub GW, Muralidharan S, Pollock SB, et al: The experimental relationship between leaflet clearance and orientation of the St Jude Medical valve in the mitral position.
J Thorac Cardiovasc Surg 1992; 103:638.
[PubMed: 1548905]
92. Sezai A, Shiono M, Orime Y, et al: Evaluation of valve sound and its effects on ATS prosthetic valves in patients' quality of life.
Ann Thorac Surg 2000; 69:507.
[PubMed: 10735689]
93. Ely JL, Emken MR, Accuntius JA, et al: Pure pyrolytic carbon: preparation and properties of a new material, On-X carbon for mechanical heart valve prostheses.
J Heart Valve Dis 1998; 7:626.
[PubMed: 9870196]
94. Laczkovics A, Heidt M, Oelert H, et al: Early clinical experience with the On-X prosthetic heart valve.
J Heart Valve Dis 2001; 10:94.
[PubMed: 11206775]
95. Birnbaum D, Laczkovics A, Heidt M, et al: Examination of hemolytic potential with the On-X(R) prosthetic heart valve. J Heart Valve Dis 2000;
96. McNicholas KW, Ivey TD, Metras J, et al: North American multicenter experience with the On-X prosthetic heart valve.
J Heart Valve Dis 2006; 15:73.
[PubMed: 16480015]
97. Gallucci V, Valfre C, Mazzucco A, et al: Heart Valve Replacement with the Hancock Bioprosthesis: A 5- to 11-Year Follow-up. New York, Yorke Medical Books, 1982; p 96.
98. D'Attellis N, Nicolas-Robin A, Delayance S, et al: Early extubation after mitral valve surgery: a target-controlled infusion of
propofol and low-dose
sufentanil.
J Cardiothorac Vasc Anesth 1997; 11:467.
[PubMed: 22395667]
99. Buckberg GD: Development of blood cardioplegia and retrograde techniques: the experimenter/observer complex.
J Card Surg 1998; 13:163.
[PubMed: 10193984]
100. Larbalestier RI, Chard RB, Cohn LH: Optimal approach to the mitral valve: dissection of the interatrial groove.
Ann Thorac Surg 1992; 54:1186.
[PubMed: 1449308]
101. Sondergaard T, Gotzsche M, Ottosen P, Schultz J: Surgical closure of interatrial septal defects by circumclusion.
Acta Chir Scand 1955; 109:188.
[PubMed: 13248393]
102. Hirt SW, Frimpong-Boateng K, Borst HG: The superior approach to the mitral valve: is it worthwhile?
Eur J Cardiothorac Surg 1988; 2:372.
[PubMed: 3272242]
103. Utley JR, Leyland SA, Nguyenduy T: Comparison of outcomes with three atrial incisions for mitral valve operations: right lateral, superior septal, and transseptal.
J Thorac Cardiovasc Surg 1995; 109:582.
[PubMed: 7877322]
104. Guiraudon GM, Ofiesh JG, Kaushik R: Extended vertical transatrial septal approach to the mitral valve.
Ann Thorac Surg 1991; 52:1058; discussion 1060.
[PubMed: 1953124]
105. Barner HB: Combined superior and right lateral left atriotomy with division of the superior vena cava for exposure of the mitral valve.
Ann Thorac Surg 1985; 40:365.
[PubMed: 4051619]
106. Selle JG: Temporary division of the superior vena cava for exceptional mitral valve exposure.
J Thorac Cardiovasc Surg 1984; 88:302.
[PubMed: 6748725]
107. Kon ND, Tucker WY, Mills SA, et al: Mitral valve operation via an extended transseptal approach.
Ann Thorac Surg 1993; 55:1413; discussion 1416.
[PubMed: 8512390]
108. Kumar N, Saad E, Prabhakar G, et al: Extended transseptal versus conventional left atriotomy: early postoperative study.
Ann Thorac Surg 1995; 60:426.
[PubMed: 7646108]
109. Cosgrove DM 3d, Sabik JF, Navia JL: Minimally invasive valve operations.
Ann Thorac Surg 1998; 65:1535; discussion 1538.
[PubMed: 9647054]
110. Mihaljevic T, Cohn LH, Unic D, et al: One thousand minimally invasive valve operations: early and late results.
Ann Surg 2004; 240:529; discussion 534.
[PubMed: 15319724]
111. Cohn LH, Adams DH, Couper GS, et al: Minimally invasive cardiac valve surgery improves patient satisfaction while reducing costs of cardiac valve replacement and repair.
Ann Surg 1997; 226:421; discussion 427.
[PubMed: 9351710]
112. Cohn LH, Couper GS, Aranki SF, et al: The long-term results of mitral valve reconstruction for the “floppy” valve.
J Card Surg 1994; 9:278.
[PubMed: 8186581]
113. Douglas JJ: Mitral Valve Replacement. Philadelphia, Saunders, 1995; p 393.
114. David TE, Armstrong S, Sun Z: Left ventricular function after mitral valve surgery. J Heart Valve Dis 1995; 4:S175.
115. Lillehei C, Levy M, Bonnabeau R: Mitral valve replacement with preservation of papillary muscles and chordae tendinae.
J Thorac Cardiovasc Surg 1964; 47:532.
[PubMed: 14180754]
116. Cohn LH, Couper GS, Kinchla NM, Collins JJ Jr: Decreased operative risk of surgical treatment of mitral regurgitation with or without coronary artery disease.
J Am Coll Cardiol 1990; 16:1575.
[PubMed: 2254541]
117. Horskotte D, Schulte HD, Bircks W, Strauer BE: The effect of chordal preservation on late outcome after mitral valve replacement: a randomized study.
J Heart Valve Dis 1993; 2:150.
[PubMed: 8261152]
118. Okita Y, Miki S, Ueda Y, et al: Midterm results of mitral valve replacement combined with chordae tendineae replacement in patients with mitral stenosis.
J Heart Valve Dis 1997; 6:37.
[PubMed: 9044074]
119. Sugita T, Matsumoto M, Nishizawa J, et al: Long-term outcome after mitral valve replacement with preservation of continuity between the mitral annulus and the papillary muscle in patients with mitral stenosis.
J Heart Valve Dis 2004; 13:931.
[PubMed: 15597585]
120. Karlson KJ, Ashraf MM, Berger RL: Rupture of left ventricle following mitral valve replacement.
Ann Thorac Surg 1988; 46:590.
[PubMed: 3190341]
121. Spencer FC, Galloway
AC, Colvin SB: A clinical evaluation of the hypothesis that rupture of the left ventricle following mitral valve replacement can be prevented by preservation of the chordae of the mural leaflet.
Ann Surg 1985; 202:673.
[PubMed: 3907548]
122. Chambers EP Jr, Heath BJ: Comparison of supra-annular and subannular pledgeted sutures in mitral valve replacement.
Ann Thorac Surg 1991; 51:60; discussion 63.
[PubMed: 1985578]
123. Antunes MJ: Technique of implantation of the Medtronic-Hall valve and other modern tilting-disc prostheses.
J Card Surg 1990; 5:86.
[PubMed: 2133835]
124. Cooley DA: Simplified techniques of valve replacement.
J Card Surg 1992; 7:357.
[PubMed: 1482830]
125. Dhasmana JP, Blackstone EH, Kirklin JW, Kouchoukos NT: Factors associated with periprosthetic leakage following primary mitral valve replacement: with special consideration of the suture technique.
Ann Thorac Surg 1983; 35:170.
[PubMed: 6337570]
126. DiSesa VJ, Tam S, Cohn LH: Ligation of the left atrial appendage using an automatic surgical stapler.
Ann Thorac Surg 1988; 46:652.
[PubMed: 3196103]
127. Cohn LH: Tricuspid regurgitation secondary to mitral valve disease: when and how to repair.
J Card Surg 1994; 9:237.
[PubMed: 8186574]
128. Svenarud P, Persson M, van der Linden J: Effect of CO
2 insufflation on the number and behavior of air microemboli in open-heart surgery: a randomized clinical trial.
Circulation 2004; 109:1127.
[PubMed: 14981007]
129. Heras M, Chesebro JH, Fuster V, et al: High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
J Am Coll Cardiol 1995; 25:1111.
[PubMed: 7897124]
130. Jegaden O, Eker A, Delahaye F, et al: Thromboembolic risk and late survival after mitral valve replacement with the St Jude Medical valve.
Ann Thorac Surg 1994; 58:1721; discussion 1727.
[PubMed: 7979743]
131. Ezekowitz MD: Anticoagulation management of valve replacement patients. J Heart Valve Dis 2002; 11:S56.
132. Meurin P, Tabet JY, Weber H, et al: Low-molecular-weight
heparin as a bridging anticoagulant early after mechanical heart valve replacement.
Circulation 2006; 113:564.
[PubMed: 16449734]
133. Laffort P, Roudaut R, Roques X, et al: Early and long-term (one-year) effects of the association of
aspirin and oral anticoagulant on thrombi and morbidity after replacement of the mitral valve with the St Jude Medical prosthesis: a clinical and transesophageal echocardiographic study.
J Am Coll Cardiol 2000; 35:739.
[PubMed: 10716478]
134. Yamak B, Iscan Z, Mavitas B, et al: Low-dose oral anticoagulation and antiplatelet therapy with St Jude Medical heart valve prosthesis.
J Heart Valve Dis 1999; 8:665.
[PubMed: 10616246]
135. Braunwald E: Valvular Heart Diseases. Philadelphia, Saunders, 2001; p 1699.
136. Aoyagi S, Oryoji A, Nishi Y, et al: Long-term results of valve replacement with the St Jude Medical valve.
J Thorac Cardiovasc Surg 1994; 108:1021.
[PubMed: 7983871]
137. Emery RW, Krogh CC, Arom KV, et al: The St Jude Medical cardiac valve prosthesis: a 25-year experience with single valve replacement.
Ann Thorac Surg 2005; 79:776; discussion 782.
[PubMed: 15734375]
138. Remadi JP, Bizouarn P, Baron O, et al: Mitral valve replacement with the St Jude Medical prosthesis: a 15-year follow-up.
Ann Thorac Surg 1998; 66:762.
[PubMed: 9768927]
139. Birkmeyer NJ, Marrin CA, Morton JR, et al: Decreasing mortality for aortic and mitral valve surgery in northern New England. Northern New England Cardiovascular Disease Study Group.
Ann Thorac Surg 2000; 70:432.
[PubMed: 10969658]
140. Okita Y, Miki S, Ueda Y, et al: Left ventricular function after mitral valve replacement with or without chordal preservation. J Heart Valve Dis 1995; 4:S181; discussion S192.
141. Arom KV, Nicoloff DM, Kersten TE, et al: Six years of experience with the St Jude Medical valvular prosthesis. Circulation 1985; 72:II-153.
142. Cohn LH, Aranki SF, Rizzo RJ, et al: Decrease in operative risk of reoperative valve surgery.
Ann Thorac Surg 1993; 56:15; discussion 20.
[PubMed: 8328847]
143. Oury JH, Cleveland JC, Duran CG, Angell WW: Ischemic mitral valve disease: classification and systemic approach to management.
J Card Surg 1994; 9:262.
[PubMed: 8186579]
144. Thourani VH, Weintraub WS, Guyton RA, et al: Outcomes and long-term survival for patients undergoing mitral valve repair versus replacement: effect of age and concomitant coronary artery bypass grafting.
Circulation 2003; 108:298.
[PubMed: 12835220]
145. Society of Thoracic Surgeons: Data Analysis of the Society of Thoracic Surgeons National Cardiac Surgery Database: The Fifth Year—January 1996. Minneapolis: Summit Medical Systems, 1996.
146. Bortolotti U, Milano A, Testolin L, et al: The Carbomedics bileaflet prothesis: initial experience at the University of Padova. Clin Rep 1991; 4.
147. Grossi EA, Galloway
AC, Miller JS, et al: Valve repair versus replacement for mitral insufficiency: when is a mechanical valve still indicated?
J Thorac Cardiovasc Surg 1998; 115:389; discussion 394.
[PubMed: 9475534]
148. Hammermeister K, Sethi GK, Henderson WG, et al: Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial.
J Am Coll Cardiol 2000; 36:1152.
[PubMed: 11028464]
149. Sidhu P, O'Kane H, Ali N, et al: Mechanical or bioprosthetic valves in the elderly: a 20-year comparison. Ann Thorac Surg 2001; 71:S257.
150. Starr A: The Starr-Edwards valve.
J Am Coll Cardiol 1985; 6:899.
[PubMed: 4031305]
151. Bernal JM, Rabasa JM, Cagigas JC, et al: Valve-related complications with the Hancock I porcine bioprosthesis: a twelve- to fourteen-year follow-up study.
J Thorac Cardiovasc Surg 1991; 101:871.
[PubMed: 2023444]
152. Cohn LH, Peigh PS, Sell J, DiSesa VJ: Right thoracotomy, femoro-femoral bypass, and deep hypothermia for re-replacement of the mitral valve.
Ann Thorac Surg 1989; 48:69.
[PubMed: 2764604]
153. Perier P, Swanson J, Takriti A, et al: Decreasing Operative Risk in Isolated Valve Re-replacement. New York, Yorke Medical Books, 1986; p 333.
154. Wideman FE, Blackstone EH, Kirklin JW, et al: Hospital mortality of re-replacement of the aortic valve: incremental risk factors.
J Thorac Cardiovasc Surg 1981; 82:692.
[PubMed: 6975401]
155. Myken PS, Caidahl K, Larsson P, et al: Mechanical versus biological valve prosthesis: a ten-year comparison regarding function and quality of life. Ann Thorac Surg 1995; 60:S447.
156. Akins C, Buckley M, Daggett W, et al: Ten-Year Follow-up of the Starr-Edwards Prosthesis. New York: Futura, 1987.
157. Akins CW: Mechanical cardiac valvular prostheses.
Ann Thorac Surg 1991; 52:161.
[PubMed: 2069453]
158. Antunes MJ, Wessels A, Sadowski RG, et al: Medtronic Hall valve replacement in a third-world population group: a review of the performance of 1000 prostheses.
J Thorac Cardiovasc Surg 1988; 95:980.
[PubMed: 3374163]
159. Beaudet RL, Nakhle G, Beaulieu CR, et al: Medtronic-Hall prosthesis: valve-related deaths and complications.
Can J Cardiol 1988; 4:376.
[PubMed: 3228765]
160. Cortina JM, Martinell J, Artiz V, et al: Comparative clinical results with Omniscience (STM1), Medtronic-Hall, and Bjork-Shiley convexo-concave (70 degrees) prostheses in mitral valve replacement.
J Thorac Cardiovasc Surg 1986; 91:174.
[PubMed: 3945084]
161. Emery RW, Krogh CC, Jones DJ, et al: Five-year follow up of the ATS mechanical heart valve.
J Heart Valve Dis 2004; 13:231.
[PubMed: 15086262]
162. Jamieson WR, Fradet GJ, Miyagishima RT, et al: CarboMedics mechanical prosthesis: performance at eight years.
J Heart Valve Dis 2000; 9:678.
[PubMed: 11041184]
163. Khan SS, Trento A, DeRobertis M, et al: Twenty-year comparison of tissue and mechanical valve replacement.
J Thorac Cardiovasc Surg 2001; 122:257.
[PubMed: 11479498]
164. Moidl R, Simon P, Wolner E: The On-X prosthetic heart valve at five years. Ann Thorac Surg 2002; 74:S1312.
165. Ohta S, Ohuchi M, Katsumoto K, et al: Comparison of long-term clinical results of the three models of the Bjork-Shiley valve prosthesis and the Omnicarbon valve prosthesis.
Nippon Kyobu Geka Gakkai Zasshi 1995; 43:1569.
[PubMed: 8530840]
166. Stefanidis C, Nana AM, De Canniere D, et al: 10-year experience with the ATS mechanical valve in the mitral position.
Ann Thorac Surg 2005; 79:1934.
[PubMed: 15919287]
167. Fradet GJ, Bleese N, Burgess J, Cartier PC: Mosaic valve international clinical trial: early performance results. Ann Thorac Surg 2001; 71:S273.
168. Jamieson W, Burr L, Allen P, et al: Quality of Life Afforded by Porcine Bioprostheses Illustrated by the New-Generation Carpentier-Edwards Porcine Bioprothesis. New York, Futura, 1987.
169. Cohn LH, Sanders JH, Collins JJ Jr: Actuarial comparison of Hancock porcine and prosthetic disc valves for isolated mitral valve replacement. Circulation 1976; 54:III-60.
170. Edmunds L: Thrombotic complications with the Omniscience valve. J Thorac Cardiovasc Surg 1989; 98:300.
171. Levantino M, Tartarini G, Barzaghi C, et al: Survival despite almost complete occlusion by chronic thrombosis of a Bjork-Shiley mitral prosthesis.
J Heart Valve Dis 1995; 4:103.
[PubMed: 7742980]
172. Manteiga R, Carlos Souto J, Altes A, et al: Short-course thrombolysis as the first line of therapy for cardiac valve thrombosis.
J Thorac Cardiovasc Surg 1998; 115:780.
[PubMed: 9576210]
173. Silber H, Khan SS, Matloff JM, et al: The St Jude valve: thrombolysis as the first line of therapy for cardiac valve thrombosis.
Circulation 1993; 87:30.
[PubMed: 8419020]
174. Hering D, Piper C, Bergemann R, et al: Thromboembolic and bleeding complications following St Jude Medical valve replacement: results of the German Experience with Low-Intensity Anticoagulation Study.
Chest 2005; 127:53.
[PubMed: 15653962]
175. Ahmad R, Manohitharajah SM, Deverall PB, Watson DA: Chronic hemolysis following mitral valve replacement: a comparative study of the Bjork-Shiley, composite-seat Starr-Edwards, and frame-mounted aortic homograft valves.
J Thorac Cardiovasc Surg 1976; 71:212.
[PubMed: 1246146]
176. Genoni M, Franzen D, Vogt P, et al: Paravalvular leakage after mitral valve replacement: improved long-term survival with aggressive surgery?
Eur J Cardiothorac Surg 2000; 17:14.
[PubMed: 10735406]
177. Burckhardt D, Striebel D, Vogt S, et al: Heart valve replacement with St Jude Medical valve prosthesis: long-term experience in 743 patients in Switzerland. Circulation 1988; 78:I-18.
178. Gallucci V, Mazzucco A, Bortolotti U, et al: The standard Hancock porcine bioprosthesis: overall experience at the University of Padova.
J Card Surg 1988; 3:337.
[PubMed: 2980035]
179. Baumgartner WA, Miller DC, Reitz BA, et al: Surgical treatment of prosthetic valve endocarditis.
Ann Thorac Surg 1983; 35:87.
[PubMed: 6849584]
180. Carrier M, Martineau JP, Bonan R, Pelletier LC: Clinical and hemodynamic assessment of the Omniscience prosthetic heart valve.
J Thorac Cardiovasc Surg 1987; 93:300.
[PubMed: 3807403]
181. Copeland JG 3d, Sethi GK: Four-year experience with the CarboMedics valve: the North American experience. North American team of clinical investigators for the CarboMedics prosthetic heart valve.
Ann Thorac Surg 1994; 58:630; discussion 637.
[PubMed: 7944682]
182. Keenan RJ, Armitage JM, Trento A, et al: Clinical experience with the Medtronic-Hall valve prosthesis.
Ann Thorac Surg 1990; 50:748.
[PubMed: 2241336]
183. Pelletier LC, Carrier M, Leclerc Y, et al: Porcine versus pericardial bioprostheses: a comparison of late results in 1593 patients.
Ann Thorac Surg 1989; 47:352.
[PubMed: 2930300]
184. Calderwood SB, Swinski LA, Waternaux CM, et al: Risk factors for the development of prosthetic valve endocarditis.
Circulation 1985; 72:31.
[PubMed: 4006134]
185. Verheul HA, van den Brink RB, van Vreeland T, et al: Effects of changes in management of active infective endocarditis on outcome in a 25-year period.
Am J Cardiol 1993; 72:682.
[PubMed: 8249845]
186. Cachera JP, Loisance D, Mourtada A, et al: Surgical techniques for treatment of bacterial endocarditis of the mitral valve.
J Card Surg 1987; 2:265.
[PubMed: 2979976]
187. Edwards MB, Ratnatunga CP, Dore CJ, Taylor KM: Thirty-day mortality and long-term survival following surgery for prosthetic endocarditis: a study from the UK heart valve registry.
Eur J Cardiothorac Surg 1998; 14:156.
[PubMed: 9755001]
188. Jault F, Gandjbakhch I, Rama A, et al: Active native valve endocarditis: determinants of operative death and late mortality.
Ann Thorac Surg 1997; 63:1737.
[PubMed: 9205176]
189. Rahimtoola SH: The problem of valve prosthesis-patient mismatch.
Circulation 1978; 58:20-24.
[PubMed: 348341]
190. Rahimtoola SH, Murphy E: Valve prosthesis-patient mismatch. A long-term sequela.
Br Heart J 1981; 45:331-335.
[PubMed: 6451234]
191. Jamieson WRE, Germann E, Ye J, et al: Effect of prosthesis-patient mismatch on long-term survival with mitral valve replacement: assessment to 15 years.
Ann Thorac Surg 2009; 87:1135-1142.
[PubMed: 19324139]
192. Gammie JS, Sheng S, Griffith BP, et al: Trends in mitral valve surgery in the United States: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database.
Ann Thorac Surg 2009; 87(5):1431-1437; discussion 1437-1439.
[PubMed: 19379881]